US 12,558,402 B2Granted

Jellyfish collagen use

AssigneesJellagen Pty Ltd, Mayo Foundation for Medical Education and Research

InventorsAndrew Mearns Spragg, Dale Ekbom, Serban San-Marina

Life of this patent

Estimating the term…

Abstract

The present invention relates to jellyfish collagen for use in the treatment of vocal fold paralysis.

Claims14

Dependent claims

A method of treating vocal fold paralysis, wherein the method comprises administering a composition comprising jellyfish collagen to a subject in need thereof, wherein the jellyfish collagen is cross-linked.

Dependencies are inferred from the claim text.

Facts

Application: 18/010,762Filed 15 Jun 2021 · us provisional application
Priority: GB 20105449 Jul 2020
Published: US 2023/0218724 A113 Jul 2023
Granted: 24 Feb 2026
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 38/39
From animals; from humans: connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
A61K 35/28
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically…:…
A61P 11/04
Drugs for disorders of the respiratory system: for throat disorders
A61P 43/00
Drugs for specific purposes, not provided for in groups a61p1/00-a61p41/00

Family

Application63/039,716Us provisional application · filed 16 Jun 2020
US 2023/0218724 A1Pre-grant publication · published 13 Jul 2023
US 12,558,402 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results